LY6H and esophageal cancer: In contrast, LY6H expression is lower in cervical squamous cell carcinoma and endometrial adenocarcinoma (CESC), colon cancer (COAD), esophageal cancer (ESCA), rectal adenocarcinoma (READ), gastric adenocarcinoma (STAD), and endometrial cancer (UCEC) than in normal tissues.